OcuSciences
Ann Arbor, United States· Est.
OcuSciences is developing ocular imagers to analyze oxidative stress to detect and monitor eye diseases. We are a biotech startup that is commercializing a retinal imager that detects and quantifies mitochondrial dysfunction in the eye.
Private Company
Total funding raised: $6.3M
About
OcuSciences is developing ocular imagers to analyze oxidative stress to detect and monitor eye diseases. We are a biotech startup that is commercializing a retinal imager that detects and quantifies mitochondrial dysfunction in the eye.
OphthalmologyDiagnosticsMedical Devices
Funding History
3Total raised:$6.3M
Series A$5M
Seed$1.2M
Grant$150K